CID 101944491

Irbesartan metabolite 1

Structural Information

Molecular Formula
C25H28N6O3
SMILES
CC(CCC1=NC2(CCC(C2)O)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)O
InChI
InChI=1S/C25H28N6O3/c1-16(32)6-11-22-26-25(13-12-19(33)14-25)24(34)31(22)15-17-7-9-18(10-8-17)20-4-2-3-5-21(20)23-27-29-30-28-23/h2-5,7-10,16,19,32-33H,6,11-15H2,1H3,(H,27,28,29,30)
InChIKey
LIDZWACDVHJFLD-UHFFFAOYSA-N
Compound name
8-hydroxy-2-(3-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

460.2223 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 461.229576 206.7
[M+Na]+ 483.211518 212.5
[M-H]- 459.215024 212.2
[M+NH4]+ 478.256123 212.0
[M+K]+ 499.185458 205.5
[M+H-H2O]+ 443.219560 195.3
[M+HCOO]- 505.220501 216.9
[M+CH3COO]- 519.236151 212.6
[M+Na-2H]- 481.196966 200.0
[M]+ 460.22175142 204.1
[M]- 460.22284858 204.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.